Sol-Gel Technologies Ltd.

SLGL Nasdaq SEC CIK 1684693
Follow Sol-Gel Technologies Ltd. Weekly email: filings, results, news

Financials

Reported figures only · latest: Q4 2025 USD · US GAAP
EPS, diluted -
Revenue by quarter
$5.4M
$17.3M
Q2 24 Q2 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income12 fiscal years
  • Revenue
  • Net income
−$40M−$20M$0$20M$40MFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$19.4M−$6.1M
FY24$11.5M−$10.6M
FY23$1.6M−$27.2M
FY22$3.9M−$14.9M
FY21$31.3M$3.2M
FY20$8.8M−$29.3M
FY19$22.9M−$24.6M
FY18$129K−$32.2M
FY17$174K−$31.6M
FY16-−$20.8M
FY15-−$9.7M
FY14--
MarginsShare of revenue
  • Operating margin
  • Net margin
−30000%−20000%−10000%0%10000%FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25−38.9%−31.6%
FY24−104.1%−91.7%
FY23−1885.8%−1752.8%
FY22−418.3%−384.3%
FY219.5%10.3%
FY20−344.7%−333.9%
FY19−113.3%−107.4%
FY18−25985.3%−24963.6%
FY17−18179.9%−18142.5%
FY16--
FY15--
FY14--
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0$10MFY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$275K
FY24−$13.9M
FY23−$17.9M
FY22−$9.7M
FY21−$7.8M
FY20−$25.7M
FY19−$23.1M
FY18−$24.5M
FY17−$26M
FY16−$18.9M
FY15−$8.3M
FY14-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Sol-Gel Technologies Ltd.
  • Healthcare median
−30000%−20000%−10000%0%10000%FY15FY17FY19FY21FY23FY25
Show the numbers
YearSol-Gel Technologies Ltd.Healthcare median
FY25−31.6%−40.6%
FY24−91.7%−60.7%
FY23−1752.8%−97.1%
FY22−384.3%−128.5%
FY2110.3%−129.2%
FY20−333.9%−136.5%
FY19−107.4%−133.7%
FY18−24963.6%−173.4%
FY17−18142.5%−176.7%
FY16-−164.8%
FY15-−183.4%
FY14-−133%

News

No stories filed under Sol-Gel Technologies Ltd. yet - coverage appears here as the news feed clusters it.